Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2016-08-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of nab-paclitaxel combined
with gemcitabine in Chinese patients with metastatic pancreatic cancer.